In recent studies, we and others observed that differential DNA methylation and a reduction in TET2 mRNA expression may be key to the pathogenesis of pulmonary hypertension in mice and humans (Joshi et al., 2020; Potus et al., 2020). The gene discussed is TET2; the disease is pulmonary arterial hypertension.